Hans Hull - Chief Business Officer at Pliant Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Business Officer
Stock Symbol
PLRX on Nasdaq
All Insider Reports
All Insider Reports

Hans Hull - trading volume in the past year for Pliant Therapeutics, Inc.

Holdings reported by Hans Hull for Pliant Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 252K $2.77M $10.99 Jan 23, 2025 Direct
Common Stock 14K $154K $10.99 Jan 23, 2025 Indirect
Stock Option (Right to Buy) 80.3K Jan 23, 2025 Direct Common Stock

Transactions reported by Hans Hull for Pliant Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.